Loading company…
Resistentia Pharmaceuticals is an Uppsala, Sweden biopharmaceutical company developing immunotherapies for allergic asthma.
Based in Uppsala, Sweden, Resistentia Pharmaceuticals is a biopharmaceutical company that develops immunotherapeutic products for allergic asthma and inflammatory disorders. The company is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in